Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in Peripheral Artery Disease of the Lower Extremities
IRCT20231117060086N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of rivaroxaban in arteriosclerosis obliterans, sponsored by Ahvaz Jundishapur University of Medical Sciences. Started Dec 2023; status: completed.
02
Drugs
rivaroxaban
03
Conditions
arteriosclerosis obliterans
Beyond the preview
Go deeper on IRCT20231117060086N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231117060086N1.